Basic Information
Basic information for PTPRG-AS1-214-25aa-2
Peptide Name PTPRG-AS1-214-25aa-2
Genome Position chr3:62262830-62262904[-]
Species Human
Peptide Sequence MTSLHVKIAKLQTFSFSHLIKLAEP
Peptide Length 25
Unique No (PTPRG-AS1-201-25aa-2,PTPRG-AS1-204-25aa-2,PTPRG-AS1-211-25aa-2,PTPRG-AS1-212-25aa-2,PTPRG-AS1-213-25aa-2,PTPRG-AS1-216-25aa,PTPRG-AS1-217-25aa-2,PTPRG-AS1-218-25aa-2,PTPRG-AS1-219-25aa-2,PTPRG-AS1-221-25aa-2,PTPRG-AS1-222-25aa-2,PTPRG-AS1-223-25aa-2,PTPRG-AS1-226-25aa-2)
Grand Average of Hydropathicity 0.36
Relative Molecular Mass 3272.83
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000241472;PTPRG-AS1
Transcript ID/Name ENST00000660182;PTPRG-AS1-214
Transcript Length 2531
Coding Ability 0.3943
DNA Sequence Corresponding to Peptide ATGACATCACTTCATGTGAAAATAGCGAAGCTCCAAACATTTTCTTTCAGTCACCTTATTAAGCTCGCTGAGCCC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :